📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Drug safety evaluation of alemtuzumab for multiple sclerosis. (2014)

First Author: Willis M

Attributed to: MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1517/14740338.2014.928691

PubMed Identifier: 24935240

Publication URI: http://europepmc.org/abstract/MED/24935240

Type: Journal Article/Review

Volume: 13

Parent Publication: Expert opinion on drug safety

Issue: 8

ISSN: 1474-0338